| 1 |
19643600 | The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation. | 2009 Sep |
1 |
| 2 |
18310471 | Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. | 2008 Jun |
1 |
| 3 |
18425418 | Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer. | 2008 Oct |
1 |
| 4 |
18636153 | The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells. | 2008 Aug |
1 |
| 5 |
18765530 | Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. | 2008 Sep 1 |
1 |
| 6 |
17351739 | SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. | 2007 Jul |
2 |
| 7 |
18025281 | Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells. | 2007 Nov |
1 |
| 8 |
16550602 | The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. | 2006 Aug 15 |
1 |
| 9 |
12531799 | Molecular sequelae of histone deacetylase inhibition in human malignant B cells. | 2003 May 15 |
1 |
| 10 |
12094258 | Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). | 2002 Jul |
1 |
| 11 |
11535817 | The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. | 2001 Sep 11 |
4 |